$0.4204
-0.0185-4.22%
At close: Aug 28, 5:00 PM EST
$0.4227
0.00230.55%
After Hours: Aug 28, 6:06 PM EST

NeuroSense Therapeutics (NRSN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | H1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | FY '25 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.13 | — | $-0.16 | $-0.20 | $-0.40 |
| Actual | $-0.19 | $-0.06 | $-0.11 | $-0.02 | $-0.44 |
| Surprise | -46.2% | — | +31.3% | +90.0% | -10.0% |
| Revenue | |||||
| Estimate | — | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — | — |
| Metric | H1 '26E | FY '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.08 | $-0.40 |
| Revenue | ||
| Consensus | $514000 | $714000 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | Mar 31, 2026 | $-0.44 | $-0.40 | -10.0 % |
| H1 | Aug 1, 2025 | $-0.19 | $-0.13 | -46.2 % |
| Q3 | Dec 18, 2024 | $-0.11 | $-0.16 | 31.3 % |
| Q2 | Sep 30, 2024 | $-0.02 | $-0.20 | 90.0 % |